Skip to main content
Springer logoLink to Springer
. 2023 May 29;40(7):3279–3280. doi: 10.1007/s12325-023-02542-w

Correction to: Real-Life Effectiveness of Apremilast for the Treatment of Psoriasis in Belgium: Results From the Observational OTELO Study

Pierre-Dominique Ghislain 1,, Jo Lambert 2, Xuãn-Lan Lam Hoai 3, Tom Hillary 4, Pierre-Paul Roquet-Gravy 5, Michel de la Brassinne 6, Siegfried Segaert 7
PMCID: PMC10272248  PMID: 37246202

Correction to: Adv Ther (2022) 39:1068–1080 10.1007/s12325-021-01981-7

The third author surname has been corrected as Xuãn-Lan Lam Hoai.

The original article has been corrected.

Data availability

The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request. Qualified researchers may request data from Amgen clinical studies. Complete details are available at the following: https://www.amgen.com/science/clinical-trials/clinical-data-transparencypractices/clinical-trial-data-sharing-request.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request. Qualified researchers may request data from Amgen clinical studies. Complete details are available at the following: https://www.amgen.com/science/clinical-trials/clinical-data-transparencypractices/clinical-trial-data-sharing-request.


Articles from Advances in Therapy are provided here courtesy of Springer

RESOURCES